SOP Guide for Pharma

Sterile Injectable Manufacturing: SOP for Weight Variation Testing of Injectable Products – V 2.0

Sterile Injectable Manufacturing: SOP for Weight Variation Testing of Injectable Products – V 2.0

Standard Operating Procedure for Weight Variation Testing of Injectable Products


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/072/2025
Supersedes SOP/SIM/072/2022
Page No. Page 1 of 13
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

This SOP outlines the procedure for performing weight variation testing of filled injectable containers to ensure uniformity in dosage units and compliance with regulatory standards.

2. Scope

This SOP is applicable to all batches of injectable products filled in vials, ampoules, or prefilled syringes

manufactured in the sterile injectable manufacturing facility.

3. Responsibilities

  • QC Analyst: Performs weight variation test as per this SOP.
  • QA Officer: Ensures compliance to procedure and reviews test data.
  • Production Officer: Supports sampling and ensures availability of required containers.

4. Accountability

The Head of Quality Control is accountable for ensuring that weight variation testing is performed and documented as per current GMP and pharmacopoeial guidelines.

5. Procedure

5.1 Sampling

  1. Collect 10 containers (vials/ampoules/syringes) randomly from the filled lot as per SOP for in-process sampling.
  2. Ensure containers are labeled appropriately and are free from external moisture.

5.2 Equipment Verification

  1. Ensure the analytical balance used for weighing is calibrated and within the valid calibration period.
  2. Record balance ID and calibration verification before use (Annexure-1).

5.3 Testing Method

  1. Weigh each filled container (Gross Weight) and record.
  2. Carefully remove the contents completely and clean the empty container.
  3. Weigh the empty container (Tare Weight) and calculate Net Weight = Gross Weight – Tare Weight.
  4. Record all readings in Annexure-2.

5.4 Acceptance Criteria

  1. Refer to applicable pharmacopeia (e.g., USP, IP) for acceptance limits, usually ±10% of label claim.
  2. If one or more units are outside acceptable limits, perform investigation as per deviation SOP.

5.5 Documentation and Review

  1. All test results must be reviewed and approved by QA.
  2. Attach test report to Batch Manufacturing Record for release.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QC: Quality Control
  • QA: Quality Assurance
  • IP: Indian Pharmacopoeia
  • USP: United States Pharmacopoeia

7. Documents

  1. Balance Calibration Verification Log – Annexure-1
  2. Weight Variation Test Record – Annexure-2
  3. Deviation Report (if any) – Annexure-3

8. References

  • USP <905> Uniformity of Dosage Units
  • Schedule M – Good Manufacturing Practices
  • WHO TRS No. 986 Annex 2

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Balance Calibration Verification Log

Date Balance ID Calibration Due Date Checked By
18/06/2025 BAL-003 30/06/2025 Sunita Reddy

Annexure-2: Weight Variation Test Record

Sample No. Gross Weight (g) Tare Weight (g) Net Weight (g) Remarks
1 5.87 1.42 4.45 Within Limit

Annexure-3: Deviation Report

Date Deviation Details Corrective Action Reviewed By
18/06/2025 Sample 8 out of limit Batch held, investigation initiated Anil Jadhav

Revision History

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Issue New SOP QA Head
18/06/2025 2.0 Updated with Annexures and Criteria Review Cycle QA Head
Exit mobile version